These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 32043553)

  • 1. Smoking cessation services in the Eastern Mediterranean Region: highlights and findings from the WHO Report on the Global Tobacco Epidemic 2019.
    AlMulla A; Hassan-Yassoub N; Fu D; El-Awa F; Alebshehy R; Ismail M; Fraser CP
    East Mediterr Health J; 2020 Jan; 26(1):110-115. PubMed ID: 32043553
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increasing Smoking Cessation in the United States: Expanding the Availability of Over-the-Counter Medications.
    Leischow SJ
    JAMA; 2019 Feb; 321(6):541-542. PubMed ID: 30653222
    [No Abstract]   [Full Text] [Related]  

  • 3. [Smoking cessation: Pharmacological strategies different from standard treatments].
    Underner M; Perriot J; Peiffer G; Harika-Germaneau G; Jaafari N
    Rev Pneumol Clin; 2018 Sep; 74(4):205-214. PubMed ID: 29773262
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nicotine receptor partial agonists for smoking cessation.
    Cahill K; Lindson-Hawley N; Thomas KH; Fanshawe TR; Lancaster T
    Cochrane Database Syst Rev; 2016 May; 2016(5):CD006103. PubMed ID: 27158893
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Current pharmacologic treatments for smoking cessation and new agents undergoing clinical trials.
    Nagano T; Katsurada M; Yasuda Y; Kobayashi K; Nishimura Y
    Ther Adv Respir Dis; 2019; 13():1753466619875925. PubMed ID: 31533544
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Moderators of real-world effectiveness of smoking cessation aids: a population study.
    Jackson SE; Kotz D; West R; Brown J
    Addiction; 2019 Sep; 114(9):1627-1638. PubMed ID: 31117151
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Status and costs of smoking cessation in countries of the Eastern Mediterranean Region.
    Heydari G; Talischi F; Mojgani N; Masjedi MR; Algouhmani H; Lando HA; Ahmady EA
    East Mediterr Health J; 2012 Nov; 18(11):1102-6. PubMed ID: 23301371
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cost-effectiveness of real-world administration of tobacco pharmacotherapy in the United States Veterans Health Administration.
    Barnett PG; Ignacio RV; Kim HM; Geraci MC; Essenmacher CA; Hall SV; Sherman SE; Duffy SA
    Addiction; 2019 Aug; 114(8):1436-1445. PubMed ID: 30924195
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modelling continuous abstinence rates over time from clinical trials of pharmacological interventions for smoking cessation.
    Jackson SE; McGowan JA; Ubhi HK; Proudfoot H; Shahab L; Brown J; West R
    Addiction; 2019 May; 114(5):787-797. PubMed ID: 30614586
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relapse prevention interventions for smoking cessation.
    Livingstone-Banks J; Norris E; Hartmann-Boyce J; West R; Jarvis M; Hajek P
    Cochrane Database Syst Rev; 2019 Feb; 2(2):CD003999. PubMed ID: 30758045
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diminishing benefit of smoking cessation medications during the first year: a meta-analysis of randomized controlled trials.
    Rosen LJ; Galili T; Kott J; Goodman M; Freedman LS
    Addiction; 2018 May; 113(5):805-816. PubMed ID: 29377409
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacological Approach to Smoking Cessation: An Updated Review for Daily Clinical Practice.
    Giulietti F; Filipponi A; Rosettani G; Giordano P; Iacoacci C; Spannella F; Sarzani R
    High Blood Press Cardiovasc Prev; 2020 Oct; 27(5):349-362. PubMed ID: 32578165
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nicotine receptor partial agonists for smoking cessation.
    Cahill K; Stead LF; Lancaster T
    Cochrane Database Syst Rev; 2010 Dec; (12):CD006103. PubMed ID: 21154363
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nicotine receptor partial agonists for smoking cessation.
    Cahill K; Stead LF; Lancaster T
    Cochrane Database Syst Rev; 2011 Feb; (2):CD006103. PubMed ID: 21328282
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nicotine receptor partial agonists for smoking cessation.
    Cahill K; Stead LF; Lancaster T
    Cochrane Database Syst Rev; 2012 Apr; (4):CD006103. PubMed ID: 22513936
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Understanding the implications of the biobehavioral basis of nicotine addiction and its impact on the efficacy of treatment.
    Bozinoff N; Le Foll B
    Expert Rev Respir Med; 2018 Sep; 12(9):793-804. PubMed ID: 30092681
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Systematic Review and Meta-Analysis to Assess the Safety of Bupropion and Varenicline in Pregnancy.
    Turner E; Jones M; Vaz LR; Coleman T
    Nicotine Tob Res; 2019 Jul; 21(8):1001-1010. PubMed ID: 29579233
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nicotine receptor partial agonists for smoking cessation.
    Cahill K; Stead LF; Lancaster T
    Cochrane Database Syst Rev; 2008 Jul; (3):CD006103. PubMed ID: 18646137
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictors of long-term abstinence rate by income level in the Korean smoking cessation programme.
    Seo YG; Paek YJ; Jo MW; Choi J
    Addiction; 2019 Nov; 114(11):2056-2064. PubMed ID: 31261447
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The efficacy of smoking cessation interventions in low- and middle-income countries: a systematic review and meta-analysis.
    Akanbi MO; Carroll AJ; Achenbach C; O'Dwyer LC; Jordan N; Hitsman B; Bilaver LA; McHugh MC; Murphy R
    Addiction; 2019 Apr; 114(4):620-635. PubMed ID: 30506845
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.